Together, these data show that ADAM2 is a cancer-testis antigen expressed in a wide variety of tumor tissues, including a high proportion of human lung cancers, and profoundly affects the tumor immune microenvironment with implications for immune therapy. The gene discussed is ADAM2; the disease is cancer.